Skip to main content Accessibility help
×
Home
  • Print publication year: 2004
  • Online publication date: August 2009

11 - Contraception and fertility

from Part II - Hormonal changes

Summary

The need for reliable, safe, and reversible contraception has become more evident, and the duration of their use has increased as many women opt to delay childbearing into the late third and fourth decades. Many psychosocial and economic factors will continue to affect women's contraceptive decision-making and undoubtedly will continue to influence rates of tubal sterilization. Vasectomy, like tubal sterilization, should be considered an irreversible sterilization procedure. The oral contraceptive pill is a common form of contraception in the USA. Numerous societal, biological, psychological, and legal factors must be considered when counseling women about their reproductive health. As with any physician-patient encounter, careful documentation must accompany any discussion regarding reproduction and contraceptive choices. Discussions regarding reproductive health, contraception, and sterilization must make the clear distinction between contraception and protection from sexually transmitted disease (STDs). Broad categories of assisted fertilization include hormonal assistance designed to induce ovulation and in vitro fertilization.
FURTHER RESOURCES
National Library of Medicine – birth control/contraception: www.nlm.nih.gov/medlineplus/birthcontrolcontraception.html
Food and Drug Administration birth control guide: www.fda.gov/fdac/features/1997/babytabl.html
Contraception Online: www.contraceptiononline.org/
Alan Guttmacher Institute. www.agi-usa.org
www.ivf/infertility.co.uk. Designed by infertility specialists primarily for couples who are experiencing difficulty in having a child and who think that they might need medical help
REFERENCES
Riphagen, F. E., Fortney, J. A. and Koelb, S.Contraception in women over forty. J. Biosoc. Sci. 1988; 20:127–42
The Alan Guttmacher Institute. Facts in brief: contraceptive use. www.agi-usa.org/pubs/fb_contr_use.html. Accessed March 17, 2003
Bouyer, J., Coste, J., Fernandez, H., Pouly, J. L. and Job-Spira, N.Sites of ectopic pregnancy: a 10-year population-based study of 1800 cases. Hum. Reprod. 2002; 17:3224–30
Anderson, R. A. and Baird, D. T.Male contraception. Endocr. Rev. 2002; 23:735–62
Stanford, J. B. and Mikolojczyk, R. T.Mechanisms of action of intrauterine devices: update and estimation of postfertilization effects. Am. J. Obstet. Gynecol. 2002; 187:1699–708
Wildemeersch, D., Schacht, E. and Wildemeersch, P.Performance and acceptability of intrauterine release of levonorgestrel with a miniature delivery system for hormonal substitution therapy, contraception and treatment in peri and postmenopausal women. Maturitas 2003; 44:237–45
Schneider, H. P.Hazards, I: perimenopausal contraception. Eur. J. Contracept. Reprod. Health Care 1997; 2:95–100
Creinin, M. D.Laboratory criteria for menopause in women using oral contraceptives. Fertil. Steril. 1996; 66:101–4
Speroff, L. and Darney, P. A Clinical Guide for Contraception. Philadelphia: Williams and Wilkins; 1996. p. 120
Andolsek, K. Contraception. In J. A. Rosenfeld (ed.) Handbook of Women's Health. Cambridge: Cambridge University Press; 2001. p. 155
Aboulghar, M. A., Mansour, R. T., Serour, G. I. and Al-Inany, H G.Diagnosis and management of unexplained fertility: an update. Arch. Gynecol. Obstet. 2003; 267:177–88
Jones, H.The infertile couple. N. Engl. J. Med. 1993; 329:1710–15
Hargreave, T. B. and Mills, A.Investigating and managing infertility in the general practice. Br. Med. J. 1998; 316:1438–41
Cohen, M. and Sauer, M.Fertility in perimenopausal women. Clin. Obstet. Gynecol. 1998; 41:958–65
Burrage, J.infertility treatment in women aged over 40 years. Nurs. Stand. 1998; 13:43–5
Hesla, J. S. Current concepts in assisted reproductive technology. In J. A. Rock, S. Faro and N. F. Gant, Jr, et al. Advances in Obstetrics and Gynecology, vol. 1. St Louis, MO: Mosby; 1994. pp. 231–58.